FDA Inspection 1069265 — Sage Therapeutics, Inc.
The FDA completed an inspection of Sage Therapeutics, Inc. on Sep 26, 2018 in Cambridge, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 26, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cambridge, MA (United States)
Additional Details
Sponsor, Contract Research Organization